List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 129 studies with search of: "Epothilones"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Phase I/II Trial of Sorafenib Plus Ixabepilone in HER2-Negative Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Interventions: Drug: Sorafenib and Ixabepilone;   Drug: Sorafenib and Ixabepilone
2 Recruiting Phase I Study of Ixabepilone + Lapatinib +/- Capecitabine to Treat HER2 Positive Locally Advanced or Metastatic Breast Cancer
Conditions: Locally Advanced Breast Cancer;   Metastatic Breast Cancer
Interventions: Drug: Ixabepilone + lapatinib;   Drug: Ixabepilone + lapatinib + capecitabine
3 Completed Ixabepilone Administered as an Enteric Coated Formulation.
Condition: Cancer
Interventions: Drug: Ixabepilone;   Drug: Ixabepilone;   Drug: Ixabepilone
4 Recruiting Randomized Phase II of Ixabepilone Alone and Ixabepilone Plus Cetuximab as First-Line Treatment for Female Subjects With Triple Negative Locally Advanced Non-Resectable and/or Metastatic Breast Cancer
Conditions: Triple Negative Locally Advanced Non-Resectable Breast Cancer;   Metastatic Breast Cancer
Interventions: Drug: ixabepilone;   Drug: ixabepilone+cetuximab
5 Active, not recruiting A Trial of 2 Schedules of Ixabepilone Plus Bevacizumab and Paclitaxel Plus Bevacizumab for Breast Cancer
Condition: Metastatic Breast Cancer
Interventions: Drug: Ixabepilone;   Drug: Ixabepilone;   Drug: Bevacizumab;   Drug: Bevacizumab;   Drug: Paclitaxel;   Drug: Bevacizumab
6 Completed Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer
Conditions: Cancer;   Breast Cancer
Interventions: Drug: Ixabepilone + Capecitabine;   Drug: Capecitabine
7 Recruiting Randomized Study of Ixabepilone Verus Observation in Patients With Significant Residual Disease
Condition: Breast Cancer
Intervention: Drug: Ixabepilone
8 Completed Novel Epothilone Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer
Conditions: Breast Cancer;   Metastases
Interventions: Drug: Ixabepilone + Capecitabine;   Drug: Capecitabine
9 Not yet recruiting Phase I Combination Ixabepilone + Cisplatin
Condition: Non Small Cell Lung Cancer
Interventions: Drug: Ixabepilone;   Drug: Cisplatin;   Drug: Ixabepilone;   Drug: Cisplatin
10 Recruiting Neoadjuvant Ixabepilone/Carboplatin/Trastuzumab in HER2-Positive Locally Advanced Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Ixabepilone;   Drug: Trastuzumab;   Drug: Carboplatin
11 Recruiting A Phase II Combination of Trastuzumab and Ixabepilone Versus Trastuzumab and Docetaxel in Patients With Advanced and/or Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Interventions: Drug: Ixabepilone & Trastuzumab;   Drug: Docetaxel & Trastuzumab
12 Recruiting Solid Tumors Using Ixabepilone and Dasatinib
Condition: Solid Tumor
Intervention: Drug: ixabepilone and dasatinib
13 Active, not recruiting A Phase II, Trial of Ixabepilone Plus Cetuximab as First Line Therapy for Metastatic Pancreatic Cancer
Condition: Metastatic Pancreatic Cancer
Intervention: Drug: Ixabepilone + Cetuximab
14 Recruiting Effect of Rifampin on the Pharmacokinetics of Ixabepilone in Patients With Advanced Cancer
Conditions: Advanced Solid Tumors;   Neoplasms
Interventions: Drug: ixabepilone;   Drug: Rifampin
15 Recruiting A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Doxorubicin;   Drug: Cyclophosphamide;   Drug: Ixabepilone (Ixempra);   Drug: Paclitaxel (Taxol)
16 Recruiting Study to Assess Effectiveness of Giving Combination of Standard Chemotherapy Drugs Versus Combination of Standard Chemotherapy and New Drug Ixabepilone When Given Before Surgical Removal of Early Stage Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Ixabepilone;   Drug: Paclitaxel;   Drug: Cyclophosphamide;   Drug: Doxorubicin
17 Completed Novel Epothilone (BMS-247550) in Patients With Metastatic Breast Cancer (MBC)
Conditions: Breast Cancer;   Metastases
Intervention: Drug: Ixabepilone
18 Active, not recruiting Ixabepilone in Combination With Carboplatin in Patients With Non-Small Cell Lung Cancer (NSCLC)
Condition: Non-Small Cell Lung Cancer
Intervention: Drug: Ixabepilone + Carboplatin
19 Recruiting A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate Cancer
Conditions: Prostatic Diseases;   Genital Neoplasms, Male;   Urogenital Neoplasms;   Genital Diseases, Male;   Adenocarcinoma;   Prostatic Neoplasms;   Neoplasms, Glandular and Epithelial;   Carcinoma
Intervention: Drug: Ixabepilone
20 Active, not recruiting A Phase I Study of Ixabepilone in Combination With Capecitabine in Japanese Patients With Metastatic Breast Cancer
Condition: Breast Cancer
Intervention: Drug: Ixabepilone + Capecitabine

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services